Suppr超能文献

ST段抬高型心肌梗死合并多支血管病变时的血运重建策略:时机与方法

Revascularization strategies in STEMI with multivessel disease: when and how.

作者信息

D'amico Gianpiero, Basile Marco, Tarantini Giuseppe, Marchese Alfredo

机构信息

Unit of Cardiology, Department of Cardiac, Thoracic, and Vascular Sciences, University of Padua Medical School, Padua, Italy -

Unit of Cardiology, GVM Care and Research, Anthea Hospital, Bari, Italy.

出版信息

Minerva Cardioangiol. 2018 Aug;66(4):429-441. doi: 10.23736/S0026-4725.18.04646-7. Epub 2018 Feb 19.

Abstract

Acute ST-segment elevation myocardial infarction (STEMI) typically arises from total occlusion of an epicardial coronary artery, most often due to atherosclerotic plaque rupture/erosion and subsequent thrombus formation. Granted this, important angiographic information for patients presenting with STEMI is not only about the status of infarct-related artery (IRA) but also about the atherosclerotic disease burden and disease severity of non-IRA vessels. Previous studies have reported that multivessel coronary artery disease is found in approximately 50% of patients with STEMI undergoing primary percutaneous coronary intervention (PCI). Primary PCI is now considered the gold standard in the treatment for patients with STEMI; however, the optimal reperfusion strategy in patients with STEMI and multivessel disease (MVD) remains uncertain. In this review, we summarize the available evidence on treatment options for patients with STEMI and MVD and highlight current guideline recommendations on this topic.

摘要

急性ST段抬高型心肌梗死(STEMI)通常由心外膜冠状动脉完全闭塞引起,最常见的原因是动脉粥样硬化斑块破裂/糜烂以及随后的血栓形成。鉴于此,对于STEMI患者而言,重要的血管造影信息不仅关乎梗死相关动脉(IRA)的状况,还涉及非IRA血管的动脉粥样硬化疾病负担和疾病严重程度。既往研究报道,在接受直接经皮冠状动脉介入治疗(PCI)的STEMI患者中,约50%存在多支冠状动脉疾病。直接PCI目前被视为STEMI患者治疗的金标准;然而,STEMI合并多支血管病变(MVD)患者的最佳再灌注策略仍不明确。在本综述中,我们总结了关于STEMI合并MVD患者治疗选择的现有证据,并强调了当前关于该主题的指南建议。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验